Skip to main content


Christopher Adlbrecht Christopher Adlbrecht, MBA, FHFA, FESCHead of Clinical Research (4th Med. Dept. Hietzing Hospital)

Department of Medicine II
Position: Associate Professor


Acute Coronary Syndrome; Heart Failure

Research group(s)

Research interests

  • Heart Failure: Prognosis, Medical Therapy;
  • Coronary Heart Disease: Coronary Intervention, Medical Therapy

Techniques, methods & infrastructure

  • Translational Research
  • Clinical Trials


  • Proteomische Analyse zur Suche nach neuen progn. Markern für das neurolog. Ergebnis nach Reanimation (2014)
    Source of Funding: OeNB (Oesterreichische Nationalbank), Anniversary Fund
    Principal Investigator

Selected publications

  1. MacDonald, M.R. et al., 2015. Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. European Journal of Heart Failure, 17(7), pp.725-734. Available at:
  2. Adlbrecht, C. et al., 2014. Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction. International Journal of Cardiology, 174(1), pp.90-95. Available at:
  3. Adlbrecht, C. et al., 2014. Peri-interventional endothelin-A receptor blockade improves long-term outcome in patients with ST-elevation acute myocardial infarction. Thrombosis and Haemostasis, 112(1), pp.176-182. Available at:
  4. Mark, D.B. et al., 2009. Quality of Life after Late Invasive Therapy for Occluded Arteries. N Engl J Med, 360(8), pp.774-783. Available at:
  5. Adlbrecht, C. et al., 2008. Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body�s red cell volume. European Heart Journal, 29(19), pp.2343-2350. Available at: